Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA Sponsors Need US FDA Permission To Avoid Last-Minute Label Update Delays
Jan 04 2024
•
By
Derrick Gingery
An ANDA must be several criteria to be approved for market without a label identical to the reference product • Source: Shutterstock
More from Generics
More from Products